The Prize Fight for Progress: Pfizer Snags Metacrine in a High-Stakes Metabolic Drug Scramble
The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle
The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care
Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal
The Silent Threat Within: How Common Fatty Liver Transforms into a Deadly Disease
The Silent Epidemic: How Obesity is Fueling a Surge in Early-Onset Type 2 Diabetes
Pfizer's Bold Gambit: Unleashing New Weapons in the Global Battle Against Obesity
The Silent Epidemic: How Malnutrition Fuels a Hidden Form of Diabetes